Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays.
about
Perspective: Adhesion Mediated Signal Transduction in Bacterial PathogensDesign of O -Acetylserine Sulfhydrylase Inhibitors by Mimicking NatureTranscriptional profiling of serogroup B Neisseria meningitidis growing in human blood: an approach to vaccine antigen discoveryStem-loop structures in prokaryotic genomesNERVE: new enhanced reverse vaccinology environmentEvaluation of reference genes for real-time RT-PCR expression studies in the plant pathogen Pectobacterium atrosepticumThe pleiotropic CymR regulator of Staphylococcus aureus plays an important role in virulence and stress responseReview of meningococcal group B vaccines.Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates.Transcriptional responses of Leptospira interrogans to host innate immunity: significant changes in metabolism, oxygen tolerance, and outer membraneThe role of glyceraldehyde 3-phosphate dehydrogenase (GapA-1) in Neisseria meningitidis adherence to human cells.CrgA is an inducible LysR-type regulator of Neisseria meningitidis, acting both as a repressor and as an activator of gene transcription.Transcriptome analysis of Neisseria meningitidis in human whole blood and mutagenesis studies identify virulence factors involved in blood survival.NafA negatively controls Neisseria meningitidis piliation.Anti-idiotypic antibody as a potential candidate vaccine for Neisseria meningitidis serogroup B.Identification of immunogenic and serum binding proteins of Staphylococcus epidermidis.Approaches to bacterial RNA isolation and purification for microarray analysis of Escherichia coli K1 interaction with human brain microvascular endothelial cells.Genome wide expression profiling reveals suppression of host defence responses during colonisation by Neisseria meningitides but not N. lactamica.Metabolism and virulence in Neisseria meningitidis.Burkholderia pseudomallei transcriptional adaptation in macrophages.An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosisCysteine depletion causes oxidative stress and triggers outer membrane vesicle release by Neisseria meningitidis; implications for vaccine developmentThe REP2 repeats of the genome of Neisseria meningitidis are associated with genes coordinately regulated during bacterial cell interactionThe environment of "Mycobacterium avium subsp. hominissuis" microaggregates induces synthesis of small proteins associated with efficient infection of respiratory epithelial cellsEvaluation of truncated NhhA protein as a candidate meningococcal vaccine antigen.RNA profiling in host-pathogen interactions.Bioinformatics: how it is being used to identify bacterial vaccine candidates.Glycoconjugate vaccines to prevent group B streptococcal infections.Identification of iron-activated and -repressed Fur-dependent genes by transcriptome analysis of Neisseria meningitidis group B.Use of the chinchilla model for nasopharyngeal colonization to study gene expression by Moraxella catarrhalisIdentification of a novel pneumococcal vaccine antigen preferentially expressed during meningitis in mice.The potential of antibody-mediated immunity in the defence against biological weapons.Towards an improved serogroup B Neisseria meningitidis vaccine.Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccineA comparison of the endotoxin biosynthesis and protein oxidation pathways in the biogenesis of the outer membrane of Escherichia coli and Neisseria meningitidis.Post-genomic vaccine development.Whole-genome comparison of disease and carriage strains provides insights into virulence evolution in Neisseria meningitidis.Transcriptional modulation of enterotoxigenic Escherichia coli virulence genes in response to epithelial cell interactionsLarge screen approaches to identify novel malaria vaccine candidates.
P2860
Q26768433-65194156-E489-41BA-B62D-6812905C3AC2Q27658287-874D50D8-D7B7-4A76-80B6-B0D2ED0118A7Q28728122-ED82868A-FF1C-4CF4-85ED-7C2042FDFB58Q33248812-232A3CAC-0059-4A85-B08B-D05544B208BDQ33250601-B4A128BF-3546-4AA3-AFEA-E74D77B1F990Q33299946-432809A8-9E33-452A-AC3A-2490E754F4C6Q33582244-FD84D6F9-E936-42D8-8DC3-F1CA40F964DDQ33646965-8EA29DB5-1A02-4926-9B0C-06772AA94B91Q33695485-2C80B564-3CA5-4CDF-8054-796629B9DF53Q33737632-DA8FCCB4-EC49-45D7-8BAC-629E356E6A11Q33742736-D363ED8D-CF8E-443B-BC1C-2D10234DE503Q33788408-D4B3B3E7-D9F1-40B8-98DB-E9AF366E544CQ33903848-EB84190D-51F5-4EC6-875E-579BEC2B8123Q33958083-5A9EFCC5-AA31-45DA-A031-1220EABDAB11Q34033132-EE989892-8736-49F6-990A-D00AED268FD3Q34033145-531D6E4C-4CF9-4918-83C7-F24B4889B071Q34041690-B6F24A4D-DD0B-4227-922B-D26968806BEEQ34058392-163D9368-FBBA-45AC-A595-FA18A9F4D50DQ34068118-745EFB32-31A6-4354-9C3D-ECB9AA458DACQ34347994-48A1264F-7C0D-4745-85D4-FBC481099C8EQ34492775-B69F2AAD-7A09-49B3-9CF1-0B2E2B582FFAQ34571107-D965E4D5-0BF0-4C5D-8F34-985C8AD80389Q34891781-0D66F9BE-08B9-46BE-A8A2-DF2ACE078A2AQ34955819-65D6CC4C-95C9-4AC1-9CB4-50CAD6635530Q34988272-70FF3191-E5D2-4CB9-B89F-60855273BB80Q35083298-736698E1-DE96-452E-981E-0D89E46249FCQ35194195-555399AE-8AFC-4C8D-90E2-CB933174ACE4Q35207531-677A6592-A5B4-438F-A519-58012D18ECCCQ35234880-9F549673-7F2A-49F5-ADF5-A44C7E329FD4Q35805451-7F4DD482-79F9-4772-8031-092C9326AA60Q36005317-5842D594-F1D9-44A6-9EAA-B34BDAA6EC9EQ36273411-92D0456C-EFCE-4749-814A-E8C79FAE8423Q36327065-F82BE40C-9C11-4617-83A8-B36E91EA1588Q36370598-572942E9-E2B7-43FF-BDA8-A085B2DA1561Q36464572-0298DE8E-6392-4B1B-87C0-02BE503B6143Q36479175-028CAAE8-C5F6-4B49-BB97-FCA6B7300D70Q36485259-8263B9EF-1FBE-4D48-BB7B-BD0C46E9C538Q36491155-2EACA3CA-825E-4962-9DAC-591EB506B0DCQ36506158-60268D4C-E0A2-4657-920C-876EADF91C00Q36510147-0D4DF88E-E9FA-4E3A-A5D6-CCE44AA6C52D
P2860
Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Previously unrecognized vaccin ...... identified by DNA microarrays.
@en
type
label
Previously unrecognized vaccin ...... identified by DNA microarrays.
@en
prefLabel
Previously unrecognized vaccin ...... identified by DNA microarrays.
@en
P2093
P356
P1433
P1476
Previously unrecognized vaccin ...... identified by DNA microarrays.
@en
P2093
Alessandro Muzzi
Brunella Brunelli
Elisabetta Frigimelica
Erika Bartolini
Filippo Randazzo
Giuliano Galli
Giulio Ratti
Guido Grandi
Hervé Tettelin
Joel Berger
P2888
P304
P356
10.1038/NBT728
P577
2002-08-12T00:00:00Z